NXTC 425: Acquisition

NextCure

Filed with the SEC on · accession 0001104659-26-130629

NXTC filed a 425 (425) with the SEC on Nov 20, 2026. NextCure announced that its board set a December 8, 2026 record date and December 14, 2026 distribution date for a pre-closing contingent value right (CVR) distribution tied to its pending merger with Avere Therapeutics.

Summary of the filing

NextCure announced that its board set a December 8, 2026 record date and December 14, 2026 distribution date for a pre-closing contingent value right (CVR) distribution tied to its pending merger with Avere Therapeutics. Each share of common and preferred stock will receive one CVR entitling holders to 90% of gross proceeds from any disposition of NextCure's pre-merger legacy assets during the CVR term.

Key details

Percentage of gross proceeds from legacy asset dispositions payable to CVR holderspercent 90
Registrant/acquirerNextCure, Inc.
Merger counterpartyAvere Therapeutics, Inc.
Wholly owned merger subsidiaryNeptune Merger Sub Corp.
Wholly owned merger subsidiaryNeptune Second Merger Sub, LLC

✦ Ask GOAX AI about this filing — what it means for NXTC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NXTC?

Click here

Frequently asked questions

What did NXTC file with the SEC on Nov 20, 2026?

NXTC filed a 425 (Acquisition). NextCure announced that its board set a December 8, 2026 record date and December 14, 2026 distribution date for a pre-closing contingent value right (CVR) distribution tied to its pending merger with Avere Therapeutics. Each share of common and preferred stock will receive one CVR entitling holders to 90% of gross proceeds from any disposition of NextCure's pre-merger legacy assets during the CVR term.

What does a acquisition mean for NXTC stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 425?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 425 (425): A report the company filed with the SEC (the US market regulator).

Other NXTC SEC filings

Get alerts when NXTC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days